Ak Asset Management Health Sector Foreign Equity Fund provides opportunity to invest in companies operating in sectors such as vaccination technologies, medication, biotechnology, genetics, and health electronics...
Ak Asset Management Health Sector Foreign Equity Fund invest in the equities of 20 companies which are the product and service developer of the health sector in approximately equal amounts.
Pfizer
Roche
Astra Zeneca
Modern
The companies that it invests in are as follows: Incyte Corp, Merck & Co Inc, Grifols SA, Eli Lilly and Co, AstraZeneca PLC, Moderna Inc, Roche Holding AG, Centene Corp, Zimmer Biomet Holdings Inc, Elanco Animal Health Inc, Teladoc Health Inc, Medtronic PLC, Novartis AG, Pfizer Inc, DexCom Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Horizon Therapeutics Plc, Boston Scientific Corp, Fresenius SE & Co KGaA
Summary Information About the Fund
With approximately equal weight Lilly and Co, AstraZeneca PLC, Moderna Inc, Roche Holding AG, Centene Corp, Zimmer Biomet Holdings Inc, Novartis AG, Pfizer Inc, DexCom Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Horizon Therapeutics Plc, Boston Scientific Corp, Fresenius SE & Co KGaA, Elanco Animal Health, Medtronic, Grifols, Incyte, Merck, Teladoc
Proposed Investment Period
Long Term (1 Year and Above)
%100 S&P Global 1200 Health Care Total Return Index (USD)
%10 Withholding (Real person) / %0 Withholding (Legal Entity)
Low Risk, High Risk, Potential Low Returns, Potential High Returns
1 2 3 4 5 6 7